ARCHIVES

BMS Execs Knew Of Flaws In ImClone Plan For C225 Prior To $2-Billion Licensing Deal

This article is from The Cancer Letter archive.

Vol. 28 No. 25 | June 21, 2002

Download PDF Visit The Full Archive

Related Articles

Court Agreement Clears The Way For Human Gene Transplant Study

May 26, 1989

In Brief: An Era Ends – Lee Clark Retires After 32 Years As Head Of UT Center; Lemaistre Succeeds Him

August 4, 1978

Guest Editorial: The Academic Difference: George Weiner On How America’s Cancer Centers Are More Valuable Than Ever

October 31, 2014

Gene Vector Labs Seek Vector Producers

February 23, 1996

In Brief: MDA Treats Only 9% Of Texas Cancer Patients; Clinical Director Search Narrows To Three

March 12, 1976

NCI Grants Awarded To Develop Special Populations Networks. AACR Honors Feinstein, Khayat.

April 7, 2000